ALZN
Price
$0.54
Change
-$0.06 (-10.00%)
Updated
May 8 closing price
Capitalization
3.56M
MDGL
Price
$299.57
Change
+$0.74 (+0.25%)
Updated
May 8 closing price
Capitalization
6.65B
89 days until earnings call
Ad is loading...

ALZN vs MDGL

Header iconALZN vs MDGL Comparison
Open Charts ALZN vs MDGLBanner chart's image
Alzamend Neuro
Price$0.54
Change-$0.06 (-10.00%)
Volume$478.82K
Capitalization3.56M
Madrigal Pharmaceuticals
Price$299.57
Change+$0.74 (+0.25%)
Volume$361.01K
Capitalization6.65B
ALZN vs MDGL Comparison Chart
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. MDGL commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ALZN: $0.54 vs. MDGL: $299.57)
Brand notoriety: ALZN and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 266% vs. MDGL: 98%
Market capitalization -- ALZN: $3.56M vs. MDGL: $6.65B
ALZN [@Biotechnology] is valued at $3.56M. MDGL’s [@Biotechnology] market capitalization is $6.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 2 bullish TA indicator(s).

  • ALZN’s TA Score: 4 bullish, 6 bearish.
  • MDGL’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than MDGL.

Price Growth

ALZN (@Biotechnology) experienced а -18.81% price change this week, while MDGL (@Biotechnology) price change was -8.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ALZN is expected to report earnings on Mar 10, 2025.

MDGL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.65B) has a higher market cap than ALZN($3.56M). MDGL YTD gains are higher at: -2.917 vs. ALZN (-53.448). ALZN has higher annual earnings (EBITDA): -4.16M vs. MDGL (-450.12M). MDGL has more cash in the bank: 926M vs. ALZN (3.36M). ALZN has less debt than MDGL: ALZN (345K) vs MDGL (120M). MDGL has higher revenues than ALZN: MDGL (180M) vs ALZN (0).
ALZNMDGLALZN / MDGL
Capitalization3.56M6.65B0%
EBITDA-4.16M-450.12M1%
Gain YTD-53.448-2.9171,833%
P/E RatioN/AN/A-
Revenue0180M-
Total Cash3.36M926M0%
Total Debt345K120M0%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFSV27.790.66
+2.43%
Dimensional US Small Cap Value ETF
FILL22.390.25
+1.13%
iShares MSCI Global Energy Producers ETF
AIA73.440.40
+0.55%
iShares Asia 50 ETF
USFI24.17N/A
N/A
BrandywineGLOBAL-U.S. Fixed Income ETF
STOT47.04-0.24
-0.51%
SPDR® DoubleLine Shrt Dur Ttl RetTactETF

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-9.40%
SRPT - ALZN
49%
Loosely correlated
-0.54%
VRAX - ALZN
41%
Loosely correlated
+2.91%
SNSE - ALZN
41%
Loosely correlated
-3.93%
NCNA - ALZN
39%
Loosely correlated
-65.83%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+0.25%
KANT - MDGL
62%
Loosely correlated
N/A
ALXO - MDGL
56%
Loosely correlated
-4.94%
ZNTL - MDGL
51%
Loosely correlated
+2.44%
CGEM - MDGL
50%
Loosely correlated
+0.91%
TSVT - MDGL
50%
Loosely correlated
N/A
More